Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 4:08 pm Purchase | 2026-06-30 | 13G | CELLECTAR BIOSCIENCES INC CLRB | Caligan Partners LP | 469,998 5.900% | 469,998 (New Position) | Filing History |
| 2026-08-14 12:11 pm Purchase | 2026-06-30 | 13G | CELLECTAR BIOSCIENCES INC CLRB | SilverArc Capital Management, LLC | 851,285 9.990% | 851,285 (New Position) | Filing History |
| 2026-08-14 12:00 pm Purchase | 2026-06-30 | 13G | CELLECTAR BIOSCIENCES INC CLRB | StemPoint Capital LP | 845,740 9.900% | 845,740 (New Position) | Filing History |
| 2026-08-14 06:02 am Purchase | 2026-06-30 | 13G | CELLECTAR BIOSCIENCES INC CLRB | BALYASNY ASSET MANAGEMENT L.P. | 798,382 9.990% | 798,382 (New Position) | Filing History |
| 2026-08-13 4:10 pm Purchase | 2026-06-30 | 13G | CELLECTAR BIOSCIENCES INC CLRB | Bleichroeder LP | 808,300 9.990% | 608,300 (+304.15%) | Filing History |
| 2026-08-04 10:06 am Purchase | 2026-06-30 | 13G | CELLECTAR BIOSCIENCES INC CLRB | Empery Asset Management, LP | 864,090 9.990% | 864,090 (New Position) | Filing History |
| 2026-06-05 12:56 pm Purchase | 2026-05-29 | 13G | CELLECTAR BIOSCIENCES INC CLRB | JANUS HENDERSON GROUP Ltd. JHG | 798,382 9.990% | 798,382 (New Position) | Filing History |
| 2026-05-11 7:05 pm Purchase | 2026-05-04 | 13G | CELLECTAR BIOSCIENCES INC CLRB | Stonepine Capital Management, LLC | 863,277 9.900% | 863,277 (New Position) | Filing History |
| 2026-02-13 4:44 pm Unchanged | 2025-12-31 | 13G | CELLECTAR BIOSCIENCES INC CLRB | Bleichroeder LP | 200,000 4.610% | 0 (Unchanged) | Filing History |
| 2026-02-10 3:23 pm Sale | 2025-12-31 | 13G | CELLECTAR BIOSCIENCES INC CLRB | Rosalind Advisors, Inc. | 247,715 5.500% | -1,377 (-0.55%) | Filing History |
| 2026-02-04 4:11 pm Purchase | 2025-12-31 | 13G | CELLECTAR BIOSCIENCES INC CLRB | Hexstone Capital LLC | 216,130 4.900% | 66,130 (+44.09%) | Filing History |
| 2025-11-14 10:46 am Purchase | 2025-09-30 | 13G | CELLECTAR BIOSCIENCES INC CLRB | Bleichroeder LP | 200,000 6.080% | 200,000 (New Position) | Filing History |
| 2025-08-14 7:39 pm Sale | 2025-06-30 | 13G | CELLECTAR BIOSCIENCES INC CLRB | ADAR1 Capital Management LLC | 2,962 0.100% | -119,862 (-97.59%) | Filing History |
| 2025-08-14 6:12 pm Sale | 2025-06-30 | 13G | CELLECTAR BIOSCIENCES INC CLRB | Laurence W. Lytton | 51,391 1.600% | -80,458 (-61.02%) | Filing History |
| 2025-08-14 4:39 pm Sale | 2025-06-30 | 13G | CELLECTAR BIOSCIENCES INC CLRB | Nantahala Capital Management LLC | 1,109 0.060% | -82,462 (-98.67%) | Filing History |
| 2025-08-08 4:05 pm Purchase | 2025-07-02 | 13G | CELLECTAR BIOSCIENCES INC CLRB | Hexstone Capital LLC | 150,000 5.600% | 150,000 (New Position) | Filing History |
| 2025-07-08 5:02 pm Sale | 2025-07-01 | 13G | CELLECTAR BIOSCIENCES INC CLRB | Mitchell P. Kopin | 140,101 4.990% | -299,230 (-68.11%) | Filing History |
| 2025-02-14 4:32 pm Sale | 2024-12-31 | 13G | CELLECTAR BIOSCIENCES INC CLRB | Nantahala Capital Management LLC | 83,571 5.730% | -39,020 (-31.83%) | Filing History |
| 2025-02-13 3:49 pm Sale | 2024-12-31 | 13G | CELLECTAR BIOSCIENCES INC CLRB | Laurence W. Lytton | 131,849 8.800% | -14,483 (-9.90%) | Filing History |
| 2025-02-03 4:57 pm Purchase | 2024-12-31 | 13G | CELLECTAR BIOSCIENCES INC CLRB | Rosalind Advisors, Inc. | 249,092 9.900% | 16,744 (+7.21%) | Filing History |